Interferon as treatment for acute hepatitis C. A meta-analysis

Area of Science:

• Hepatology and Viral Gastroenterology
• Pharmacological Interventions for Viral Infections

Background:

• Acute hepatitis C virus (HCV) infection poses a significant public health challenge.
• Limited data exists on the efficacy of short-course, low-dose interferon therapy for acute HCV.

Purpose of the Study:

• To evaluate the effectiveness of a three-month, low-dose interferon regimen for treating acute hepatitis C.
• To assess viral clearance and biochemical normalization following interferon treatment.

Main Methods:

• Meta-analysis of nine controlled trials (five randomized, four non-randomized).
• Outcomes included normal serum aminotransferases and absence of HCV RNA post-treatment.
• Eight trials compared interferon to no treatment; one compared different interferon schedules.

Main Results:

• Interferon treatment showed significant improvements in both aminotransferase normalization (+0.31) and HCV RNA clearance (+0.44).
• High methodological quality of included studies was noted.
• All trials focused on short-term biochemical and virological outcomes.

Conclusions:

• Short-course, low-dose interferon is significantly more effective than no treatment for acute hepatitis C.
• It leads to higher rates of viral clearance and normal aminotransferases 12 months post-treatment.
• Long-term studies are required to assess clinical relevance, including chronicity rates, before widespread recommendation.